| EPE064 | Improving TLD transition coverage among people living with HIV in Nkurenkuru District, Namibia | E-poster | Implementation science of scaling up HIV treatment |
| EPE274 | Improving treatment outcomes among adolescents and young people living with HIV in the coastal region of Kenya through operation triple zero (OTZ) | E-poster | Making health systems work for adolescents |
| EPE075 | Improving uptake of viral load tests by key populations in Zambia: a review of two models | E-poster | Scaling up access to models of integrated services (HIV, hepatitis, STI and other services, such as harm reduction, SRHR, gender affirming care, TB, NCDs and mental health) |
| EPE425 | Improving viral load coverage and suppression in four Central American countries during the COVID-19 pandemic | E-poster | Optimizing HIV services (prevention, testing and/or treatment) in the COVID-19 era |
| EPE362 | Improving viral load suppression in four provinces of Mozambique using a tool for early identification of unsuppressed patients | E-poster | Approaches to using data to improve programming |
| EPB208 | Improving viral load suppression rate among paediatricpatientson anti-retroviral therapy in Central Province, Zambia | E-poster | ARV management strategies in paediatric and adolescent populations |
| EPD278 | Improving viral load suppression rates among children and adolescents living with HIV through strong clinic community collaboration across 5 district in Southwestern Uganda | E-poster | Intersectional identities and multiple vulnerabilities to HIV and co-infections |
| EPC329 | Improving viral load testing uptake for HIV infected cohort on antiretroviral therapy (ART) at a rural setting: lessons learnt from Neno district, Malawi | E-poster | Measuring and enhancing retention and adherence in HIV prevention programmes |
| PEMOA29 | In vitro release and in vivo pharmacokinetics of antiretroviral drugs from ultra-long-acting polymeric implants: towards better outcomes for HIV prevention and treatment | Poster exhibition | ARVs, small molecules and immunomodulating agents - pharmacodynamics and pharmacokinetics |
| EPC279 | In vivo pharmacokinetics and safety in mice for ultra-long-acting injectable, biodegradable, and removeable in-situ forming implant with cabotegravir for HIV prevention | E-poster | Sexuality, gender and prevention technologies (including condoms, treatment as prevention, medical male circumcision, pre-exposure prophylaxis) |